Marjo Nylund
MSc
Turku PET Centre marjo.k.nylund@utu.fi +358 29 450 4743 +358 50 472 8266 Itäinen Pitkäkatu 4 Turku |
1 of 2
- Broad rim lesions are a new pathological and imaging biomarker for rapid disease progression in multiple sclerosis (2025)
- Nature MedicineMultiple Sclerosis and Related Disorders
- (2025)
- BMJ neurology open
- Longitudinal accumulation of glial activation measured by TSPO-PET predicts later brain atrophy in multiple sclerosis (2025)
- Journal of Neuroinflammation
- Plasma CHI3L1 associates with brain volume loss and glial activation in multiple sclerosis (2025)
- Journal of Neurology, Neurosurgery and PsychiatryBrain Communications
- Predictors of risk of secondary progression in multiple sclerosis (2025)
- Therapeutic Advances in Neurological DisordersMultiple Sclerosis
- Serum glial fibrillary acid protein associates with TSPO-expressing lesions in multiple sclerosis brain (2025) Sjöros, Tanja; Saraste, Maija; Matilainen, Markus; Nylund, Marjo; Koivumäki, Mikko; Kuhle, Jens; Leppert, David; Airas, Laura
- (2025)
- Neurology, Neuroimmunology and NeuroinflammationMultiple Sclerosis and Related Disorders
- A Novel Comprehensive Epigenomic Liquid Biopsy Assay Reveals Disease Biology in Multiple Sclerosis Patients from 1 mL of PlasmaTSPO-Detectable Chronic Active Lesions Predict Disease Progression in Multiple Sclerosis (2024)
- Multiple SclerosisEuropean Journal of Neurology
- Innate Immune Cell-Related Pathology in the Thalamus Signals a Risk for Disability Progression in Multiple Sclerosis (2024)
- EJNMMI ResearchJournal of Neurology
- (2024)
- Frontiers in Neurology
- Synaptic density in multiple sclerosis: An in vivo study using [11C]UCB-J-PET imaging (2024)
- TSPO-PET-measurable microglial activity remains unaltered in cladribine-treated RRMS patientsBrain TSPO-PET predicts later disease progression independent of relapses in multiple sclerosis (2024)
- Multiple SclerosisNeurology, Neuroimmunology and Neuroinflammation
- Early prognosticators of later TSPO-PET-measurable microglial activation in multiple sclerosisPhenotyping of multiple sclerosis lesions according to innate immune cell activation using TSPO-PET2023
- Longitudinal stability of progression-related microglial activity during teriflunomide treatment in patients with multiple sclerosis (2023)
- PET-measurable innate immune cell activation reduction in chronic active lesions in PPMS brain after rituximab treatment: a case report (2023)
- 2023
- Neurology, Neuroimmunology and Neuroinflammation
- (2022)
- (2022)
- (2020)
- Brain
- (2020)
UTU Research Portal